1TB0.F Strategic Partners A/S

Healthcare Biotechnology Frankfurt Exchange
76.00 EUR
Close of Nov 11, 2026
69.00 111.50
Market cap
EUR 4.11M
P/E
18.3x
P/B
1.55x
ROE
-4.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 1TB0.F undervalued?

Graham number
Price76.00
Graham value67.59
Premium12.4%

1TB0.F trades 12.4% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Strategic Partners A/S fundamental analysis

No fundamental analysis for Strategic Partners A/S yet.

Strategic Partners A/S stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Strategic Partners A/S

Strategic Partners A/S does not have significant operations. Previously, it was engaged in biotech activities. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 2024. Strategic Partners A/S was incorporated in 2009 and is based in Herlev, Denmark.

Full company profile